V. Visconti

发表

Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature

S. H. van der Burg, J. Haanen, M. van Diepen, 2017, Cancer Immunology Research.

Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight mass spectrometry assay solves misidentification of rapidly growing mycobacteria.

G. Raponi, M. Ghezzi, M. Venditti, 2016, American journal of infection control.

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial

I. Ruscito, I. Zizzari, L. Pierelli, 2016, International journal of oncology.

HPV induced triple neoplasms: a case report.

P. Benedetti Panici, M. Nuti, D. French, 2009, American journal of obstetrics and gynecology.

Nosocomial-acquired and community-onset Clostridium difficile infection at an academic hospital in Italy: Epidemiology, recurrences and toxin genes distribution.

G. Raponi, A. Giordano, V. Visconti, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Candidaemia in a tertiary care academic hospital in Italy. The impact of C. parapsilosis complex on the species distribution and antifungal susceptibility

G. Raponi, M. Ghezzi, A. Giordano, 2017, Journal of medical microbiology.

The Correlation Between Biofilm Production and Catheter-Related Bloodstream Infections Sustained by Candida. A Case Control Study.

G. Raponi, M. Ghezzi, A. Giordano, 2017, Advances in experimental medicine and biology.

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

M. Ulivelli, M. Sormani, D. Landi, 2021, eBioMedicine.

Clostridium difficile infection and Candida colonization of the gut: is there a correlation?

G. Raponi, M. Ghezzi, V. Visconti, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer

S. H. van der Burg, M. Welters, A. Valentijn, 2016, Cancer Immunology, Immunotherapy.

Immune Effects of Trastuzumab

P. Benedetti‐Panici, I. Ruscito, I. Zizzari, 2011, Journal of Cancer.

Past, present and future strategies of immunotherapy in gynecological malignancies.

M. Gasparri, I. Ruscito, P. Benedetti Panici, 2013, Current molecular medicine.

Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression

L. Frati, C. Marchetti, A. Rughetti, 2009, Journal of cellular and molecular medicine.

Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View

P. Benedetti‐Panici, M. Gasparri, I. Ruscito, 2011, Clinical & developmental immunology.

Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination

A. Sette, M. Bassetti, A. Grifoni, 2022, Vaccines.

Management and treatment of Magnusiomyces capitatus (Geotrichum capitatum) pleural infection in a non-neutropenic patient with posaconazole. A new therapeutic opportunity?

G. Raponi, G. Ferretti, V. Visconti, 2016, The new microbiologica.

Rapid diagnosis of SARS-CoV-2 pneumonia on lower respiratory tract specimens

B. Bruzzone, V. Ricucci, V. De Pace, 2021, BMC Infectious Diseases.

RT-PCR for the diagnosis of Clostridium difficile infection: the final answer has yet to come

G. Raponi, A. Giordano, V. Visconti, 2017, Journal of Clinical Pathology.

Immunology of gynecologic neoplasms: analysis of the prognostic significance of the immune status.

L. Frati, M. Nuti, P. Panici, 2009, Current Cancer Drug Targets.

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

M. Ulivelli, M. Sormani, D. Landi, 2022, eBioMedicine.